Year archive

IMUGENE LIMITED — 2014 filings

All 57 regulatory filings released by IMUGENE LIMITED (IMU) in 2014, sourced directly from the official regulator.

57 Filings

2014 Period

2014 filings (57)

Filing	Released	Lang
New milestones in preparation for HER-Vaxx clinical trial 2 pages 68.6KB Regulatory Filings	2014-12-29	English
Notice under section 708A of the Corporations Act 1 Capital/Financing Update	2014-12-17	English
Completion of share purchase plan allotment 1 page Capital/Financing Update	2014-12-15	English
Change of Director's Interest Notice (OB) 2 pages 142.1KB Director's Dealing	2014-12-15	English
Change of Director's Interest Notice (PH) 2 pages 141.3KB Director's Dealing	2014-12-15	English
Ceasing to be a substantial holder 1 page 62.1KB Major Shareholding Notification	2014-12-15	English
Change in substantial holding 2 pages 318.7KB Major Shareholding Notification	2014-12-15	English
Ceasing to be a substantial holder 1 page 695.9KB Regulatory Filings	2014-12-15	English
Ceasing to be a substantial holder 1 page 835.4KB Regulatory Filings	2014-12-15	English
Appendix 3B 13 pages 344.7KB Capital/Financing Update	2014-12-14	English
Further placement & close of SPP raising over $3.5m in total 2 pages 66.0KB Capital/Financing Update	2014-12-08	English
Release of Shares from Escrow 1 page 45.3KB Capital/Financing Update	2014-12-04	English
New Research Note available from Edison Investment Research 1 Report Publication Announcement	2014-12-03	English
HER-Vaxx peptides demonstrate high level of activity 2 pages 73.8KB Regulatory Filings	2014-11-30	English
Imugene to divest Linguet drug delivery technology 2 pages 65.3KB Capital/Financing Update	2014-11-27	English
Publication of Research Note 1 page 59.3KB Report Publication Announcement	2014-11-27	English
Extension of Share Purchase Plan Closing Date 1 pag Capital/Financing Update	2014-11-26	English
AGM 2014 Presentation 24 pages 2.0MB AGM Information	2014-11-24	English
Results of Meeting 1 page 61.4KB Declaration of Voting Results & Voting Rights Announcements	2014-11-24	English
Placement Cleansing Notice 1 page 67.2KB Capital/Financing Update	2014-11-12	English
Appendix 3B 12 pages 305.3KB Capital/Financing Update	2014-11-11	English
Additional placement details 2 pages 60.3KB Capital/Financing Update	2014-11-11	English
Share Purchase Plan Offer Document & Cleansing Notice 8 pages 659.5KB Capital/Financing Update	2014-11-06	English
Investor Presentation 28 pages 3.8MB Investor Presentation	2014-11-04	English
Share Purchase Plan Cleansing Notice 1 page 63.6KB Share Issue/Capital Change	2014-11-04	English
Capital raising for clinical development of HER-Vaxx 4 pages 80.6KB Capital/Financing Update	2014-11-04	English
Correction to Record Date of Share Purchase Plan 1 Capital/Financing Update	2014-11-04	English
Trading Halt 2 pages 169.1KB Capital/Financing Update	2014-11-02	English
Appendix 4C - quarterly 5 pages 176.9KB Interim / Quarterly Report	2014-10-30	English
Annual Report to shareholders 74 pages 1.5MB Annual Report	2014-10-23	English
Notice of Annual General Meeting/Proxy Form 19 pages 266.8KB AGM Information	2014-10-23	English
Resignation of Director 3 pages 246.9KB Board/Management Information	2014-10-22	English
Investor Presentation 23 pages 3.4MB Investor Presentation	2014-10-20	English
Imugene HER-Vaxx patent granted in US 1 page 105.1K Regulatory Filings	2014-10-07	English
Investor Presentation 26 pages 3.6MB Investor Presentation	2014-09-15	English
Swiss Drug Manufacturer to Speed Her-Vaxx Development 1 Capital/Financing Update	2014-09-14	English
Research Agreement with Medical University of Vienna 1 Regulatory Filings	2014-09-07	English
Investor Newsletter 4 pages 929.3KB Investor Presentation	2014-08-27	English
Appendix 4E and Annual Financial Report 71 pages 1.0MB Annual Report	2014-08-27	English
Charles Walker appointed Imugene CEO 2 pages 124.9KB Board/Management Information	2014-08-25	English
HER-Vaxx patent application receives US Notice of Allowance 1 Regulatory Filings	2014-07-28	English
Appendix 4C - quarterly 5 pages 169.9KB Interim / Quarterly Report	2014-07-24	English
Mymetics Engaged to Manufacture HER-Vaxx 2 pages 193.8KB Regulatory Filings	2014-07-15	English
Initial Director's Interest Notice 2 pages 36.0KB Director's Dealing	2014-07-07	English
Otto Buttula appointed Non-Executive Director 2 pages 53.2KB Board/Management Information	2014-07-06	English
Investor Update 4 pages 3.2MB Investor Presentation	2014-06-10	English
Imugene Commences Manufacture of its Gastric Cancer Vaccine 2 pages 189.3KB Capital/Financing Update	2014-05-26	English
Change in substantial holding 2 pages 753.6KB Regulatory Filings	2014-05-04	English
Gastric cancer specialist joins Imugene SAB 1 page Board/Management Information	2014-04-22	English
Appendix 4C - quarterly 5 pages 152.8KB Interim / Quarterly Report	2014-04-22	English
Change of Director's Interest Notice (NE) 2 pages 50.6KB Director's Dealing	2014-04-16	English
Imugene Allowed Israel Patent for Cancer Vaccine 1 Regulatory Filings	2014-03-23	English
IMU Commences FDA IND Process for Gastric Cancer vaccine 2 pages 148.4KB Regulatory Filings	2014-03-16	English
Half Yearly Report and Accounts 23 pages 736.4KB Interim / Quarterly Report	2014-02-26	English
Imugene Investor Update 6 pages 2.7MB Investor Presentation	2014-02-24	English
Appendix 4C - quarterly 5 pages 158.8KB Interim / Quarterly Report	2014-01-28	English
Scientific Advisory Board Appointments 1 page 119.1 Board/Management Information	2014-01-19	English

Filings by year

2026 52 filings
2025 103 filings
2024 70 filings
2023 105 filings
2022 122 filings
2021 150 filings
2020 90 filings
2019 69 filings
2018 66 filings
2017 58 filings
2016 52 filings
2015 60 filings
2014 57 filings
2013 64 filings
2012 41 filings
2011 13 filings
2010 20 filings
2009 17 filings
2008 34 filings
2007 35 filings
2006 29 filings
2005 31 filings
2004 50 filings
2003 40 filings
2002 12 filings